| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.17 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |